Rethinking Preventive Medicine

The conversation delves into the shortcomings of current medical practices regarding atherosclerosis, emphasizing the need to treat causative agents rather than merely modifying risk factors. Age is highlighted as a significant driver of risk, illustrating the disparity between older and younger patients despite seemingly healthy metrics. The focus remains on individual treatment decisions, prioritizing personal health over societal considerations.